| Predicate |
Object |
| contentType |
Journal Article|Research Support, Non-U.S. Gov't |
| endingPage |
105 |
| issn |
1473-1150
1470-269X |
| issueIdentifier |
1 |
| pageRange |
102-105 |
| publicationName |
The Pharmacogenomics Journal |
| startingPage |
102 |
| bibliographicCitation |
Shiota M, Narita S, Habuchi T, Eto M. Validated prognostic significance of YB-1 genetic variation in metastatic prostate cancer. Pharmacogenomics J. 2021 Feb;21(1):102–5. doi: 10.1038/s41397-020-00188-3. PMID: 32963329. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26b4e95f01fb5ff1a30f8d2577708ca7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dced2d91cc1d739b979454e2f3e4484c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c6399fed18bd418cae2926ff85e4a2b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3306-4858 |
| date |
2020-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/32963329
https://doi.org/10.1038/s41397-020-00188-3 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1470-269X
https://portal.issn.org/resource/ISSN/1473-1150
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22416 |
| language |
English |
| source |
https://scigraph.springernature.com/
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Validated prognostic significance of YB-1 genetic variation in metastatic prostate cancer |
| discusses |
http://id.nlm.nih.gov/mesh/M0124261
http://id.nlm.nih.gov/mesh/M0001103
http://id.nlm.nih.gov/mesh/M0192760 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1ad0f1b3b379747d7829e994c31446d1 |